CPRX Q3 2019 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M

Gross Profit

$27M85.8% margin

Operating Income

$14M44.8% margin

Net Income

$14M44.1% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$16M

Stock-Based Comp.

$817,060

Balance Sheet

Total Assets

$97M

Total Liabilities

$19M

Stockholders' Equity

$78M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$0	—
Gross Profit	$27M	-$5M	+684.1%
Operating Income	$14M	-$8M	+269.2%
Net Income	$14M	-$8M	+273.9%